Back to search

University of Kent,

Investigating the potential of Succinate dehydrogenase as an anti-fungal drug target in Candida glabrata

Abstract

dc:description.abstract

Candida glabrata is an opportunist human fungal pathogen which causes disease in immuno-compromised patients and is highly drug resistant to commonly prescribed anti-fungal drugs such as Fluconazole. This project tested whether Lonidamine (LND) has potential as a new antifungal agent. LND has shown to be safe in the mouse model so suggests it can be used in humans and has also recently been shown to inhibit Succinate dehydrogenase (complex II of the mitochondrial respiratory chain). LND caused a reduction in the C. glabrata biofilm and its ability to form colonies. Flocculation during growth assays suggested that LND causes disruptions of the cell wall. Respirometry analysis suggested LND does not utilise the ETC when SDH is inhibited and relies on the compensatory metabolic pathway known as the glyoxylate cycle. Through S. cerevisiae mutant studies, weak points within metabolic pathways were found to be ICL1 (within the glyoxylate cycle) and LSC2 (within the TCA cycle). Future research on combinational drug therapy of using LND alongside inhibitors of ICL1 or LSC2 would be crucial.

Degree

thesis:*
Level dc:type.qualificationlevel
mres
Grantor dc:publisher.institution
University of Kent,
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Currie, Andrew
Advisor dc:contributor.advisor
  • Gourlay, Campbell

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Kent
Base URL
kar.kent.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Currie, Andrew. Investigating the potential of Succinate dehydrogenase as an anti-fungal drug target in Candida glabrata. mres thesis, University of Kent,, 2021.